129 related articles for article (PubMed ID: 9362238)
1. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors.
Chen X; DiMaggio DA; Han SP; Westfall TC
Am J Physiol; 1997 Oct; 273(4):H1737-44. PubMed ID: 9362238
[TBL] [Abstract][Full Text] [Related]
2. Modulation of intracellular calcium transients and dopamine release by neuropeptide Y in PC-12 cells.
Chen X; Westfall TC
Am J Physiol; 1994 Mar; 266(3 Pt 1):C784-93. PubMed ID: 8166242
[TBL] [Abstract][Full Text] [Related]
3. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
DiMaggio DA; Farah JM; Westfall TC
Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y receptor subtypes, Y1 and Y2.
Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
Gibbs JL; Diogenes A; Hargreaves KM
Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y receptors involved in calcium channel regulation in PC12 cells.
McCullough LA; Egan TM; Westfall TC
Regul Pept; 1998 Sep; 75-76():101-7. PubMed ID: 9802399
[TBL] [Abstract][Full Text] [Related]
8. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
Gardner A; Westfall TC; Macarthur H
J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
[TBL] [Abstract][Full Text] [Related]
9. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells.
McCullough LA; Egan TM; Westfall TC
Am J Physiol; 1998 May; 274(5):C1290-7. PubMed ID: 9612216
[TBL] [Abstract][Full Text] [Related]
12. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells).
Cao G; Gardner A; Westfall TC
Biochem Pharmacol; 2007 May; 73(9):1446-54. PubMed ID: 17286966
[TBL] [Abstract][Full Text] [Related]
14. Evidence for further heterogeneity of the receptors for neuropeptide-Y and peptide-YY in tumor cell lines derived from neural crest.
Inui A; Sano K; Miura M; Hirosue Y; Nakajima M; Okita M; Baba S; Kasuga M
Endocrinology; 1992 Nov; 131(5):2090-6. PubMed ID: 1330489
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
Browning KN; Travagli RA
J Physiol; 2003 Jun; 549(Pt 3):775-85. PubMed ID: 12730340
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
Misra S; Murthy KS; Zhou H; Grider JR
J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Yeo A; Henderson G
Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function.
Sheikh SP
Am J Physiol; 1991 Nov; 261(5 Pt 1):G701-15. PubMed ID: 1659217
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
